RAPID COMMUNICATION
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
José Gomes BatistaI,,II,
, José Maria Soares JrI,,III, Carla Cristina MaganhinI, Ricardo Santos SimõesIII, Geraldez TomazII, Edmund Chada BaracatI,III
Corresponding author
I Federal University of São Paulo (UNIFESP), Gynecology Department, São Paulo/SP, Brazil
II Federal University of Paraíba (UFPB), Obstetrics and Gynecology Department, João Pessoa/PB, Brazil
III Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Gynecology Department, São Paulo/SP, Brazil
Read
357
Timeswas read the article
181
Total PDF
176
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 2 | 1 | 3 |
| 2024 June | 20 | 8 | 28 |
| 2024 May | 14 | 15 | 29 |
| 2024 April | 14 | 20 | 34 |
| 2024 March | 15 | 14 | 29 |
| 2024 February | 9 | 10 | 19 |
| 2024 January | 12 | 8 | 20 |
| 2023 December | 8 | 15 | 23 |
| 2023 November | 10 | 16 | 26 |
| 2023 October | 11 | 21 | 32 |
| 2023 September | 12 | 21 | 33 |
| 2023 August | 9 | 8 | 17 |
| 2023 July | 6 | 10 | 16 |
| 2023 June | 7 | 1 | 8 |
| 2023 May | 2 | 0 | 2 |
| 2023 April | 3 | 1 | 4 |
| 2023 March | 7 | 0 | 7 |
| 2023 February | 9 | 11 | 20 |
| 2023 January | 3 | 0 | 3 |
| 2022 December | 3 | 1 | 4 |
Show all